Rusnano, the Russia Corporation of Nanotechnologies, is working to develop nanodrugs for cancer treatment. Its goal: Production facilities by 2014 for cancer-fighters with systems of targeted delivery--liposomes, immunoliposomes, and monoclonal antibodies. Release